Author/Authors :
Rakesh K. Jain، نويسنده , , Conrad F. Piskorz، نويسنده , , Khushi L. Matta، نويسنده ,
Abstract :
Stereoselective syntheses of 6-O---SO3Na-Gal-β-(1→3)-GalNAc-α-OR (10), 6-O---SO3Na-Gal-β-(1→3)-6-O---SO3Na-GalNAc-α-OR (11), 3-O---SO3Na-Gal-β-(1→3)GalNAc-α-OR (13), 6-O---SO3Na-Gal-β-(1→3) [NeuAc-α-(2→6)]-GalNAc-α-OR (15), Gal-β-(1→3) [NeuAc-α-(2→6)]-GlcNAc-β-OR (18) and 6-O---SO3Na-Gal-β-(1→3) [NeuAc-α-(2→6)]-GlcNAc-β-OR (19) were accomplished through utilization of two key glycosyl donors, namely, 2,3,4-tri-O-benzoyl-6-O-bromoacetyl-α- -galactopyranosyl bromide (3) and 2,4,6-tri-O-acetyl-3-O-chloroacetyl-α- -galactopyranosyl bromide (4). The synthesized compounds were evaluated as ligands for CD22 adhesion protein.
Abstract
Synthesis of 6-O-SO3NaGal-β-(1→3)-GalNAc-α-OR (10), 6-O-SO3NaGal-β-(1→3)-6-O-SO3NaGalNAc-α-OR (11), 3-O-SO3NaGal-β-(1→3)GalNAc-α-OR (13), 6-O-SO3NaGal-β-(1→3) NeuAc-α-(2→6) -GalNAc-α-OR (15), Gal-β-(1→3) NeuAc-α- (2→6) -GlcNAc-β-OR (18) and 6-O-SO3NaGal-β-(1→3) NeuAc-α-(2→6) -GlcNAc-β-OR (19) were accomplished